Key Finding
Electroacupuncture performed three times weekly for 16 weeks significantly improved hormone levels, metabolic markers, inflammatory indicators, and ovulation rates in women with obesity-related PCOS compared to sham acupuncture.
Polycystic ovary syndrome (PCOS) is one of the most common hormonal conditions affecting women of reproductive age, causing irregular periods, excess androgen hormones, weight gain, and difficulties with fertility. Many women are looking for complementary approaches alongside conventional treatment, and a new clinical study suggests that electroacupuncture may offer meaningful benefits.
In this randomized controlled trial published in the African Journal of Reproductive Health, 120 women with obesity-related PCOS were divided into two groups: one received real electroacupuncture and the other received sham (fake) acupuncture. Both groups were treated three times per week for 16 weeks. Electroacupuncture involves the use of small electrical currents passed through acupuncture needles to enhance stimulation.
The results were impressive across multiple areas. Women who received real electroacupuncture showed significant improvements in hormone levels — including reductions in testosterone and luteinizing hormone (LH), and increases in progesterone and sex hormone-binding globulin. These hormonal shifts are important because they reflect a more balanced reproductive environment.
Metabolically, the electroacupuncture group saw improvements in cholesterol, blood sugar, fasting insulin, and insulin resistance — all key concerns for women with PCOS who are at higher risk for type 2 diabetes. Inflammation markers like CRP, IL-6, and TNF-α also dropped significantly. Vitamin D levels increased, which is notable given how commonly deficient PCOS patients are in this nutrient.
Perhaps most meaningfully for women hoping to conceive, ovulation rates improved, ovarian volume decreased, and antral follicle counts normalized. Hirsutism (unwanted hair growth) was also reduced, and participants reported a better quality of life.
These findings suggest electroacupuncture could be a valuable addition to a PCOS treatment plan. Always seek care from a licensed and experienced acupuncture practitioner who is familiar with reproductive health conditions.
This 16-week randomized controlled trial (n=120) evaluated electroacupuncture versus sham acupuncture in women with obesity-related PCOS, with treatment administered three times weekly. Active electroacupuncture produced statistically significant reductions in LH, LH/FSH ratio, testosterone, and anti-Müllerian hormone, alongside increases in SHBG and progesterone. Metabolic outcomes included improvements in triglycerides, LDL, total cholesterol, fasting glucose, fasting insulin, HOMA-IR, uric acid, and HDL. Inflammatory markers — CRP, IL-6, TNF-α, WBC, C3, and C4 — were significantly attenuated. Clinically, electroacupuncture improved ovulation rate, reduced hirsutism, decreased ovarian volume and antral follicle count, and enhanced quality of life scores. The breadth of endocrine, metabolic, and inflammatory improvements positions electroacupuncture as a clinically relevant adjunct for PCOS management, particularly in patients with concurrent insulin resistance and anovulation. Larger multicentre trials with longer follow-up are warranted to confirm durability of effect.
Browse our directory of verified licensed practitioners near you.
Find a practitioner →📌 Breast cancer patients who received preoperative auricular electroacupuncture for three days before surgery had significantly lower anxiety, better sleep, higher postoperative recovery quality scores, and reduced NSAID use compared to sham controls.
📌 Intraoperative electroacupuncture at PC6 and PC4 significantly reduced the incidence of slow flow/no-reflow during PCI for acute myocardial infarction from 26.7% in controls to 6.7% in the treated group (RR 0.2; P=.04).
📌 Perioperative TEAS at LI4, PC6, ST36, and SP6 significantly reduced postoperative fatigue syndrome incidence and fatigue scores in elderly patients undergoing laparoscopic radical gastrectomy, alongside lower pain scores, reduced opioid consumption, and favorable anti-inflammatory and antioxidant biomarker changes.